Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 425 | 247 | 56 | 110 | 135 |
| Receivables | 16 | 16 | 16 | 7 | 15 |
| Inventories | 8 | 15 | 6 | 7 | 10 |
| TOTAL | $453 | $282 | $81 | $163 | $164 |
| Non-Current Assets | |||||
| PPE Net | 7 | 9 | 12 | 14 | 16 |
| TOTAL | $7 | $9 | $12 | $14 | $16 |
| Total Assets | $460 | $291 | $93 | $177 | $181 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 710 | 790 | 1,425 | 1,593 | 1,273 |
| Accrued Expenses | N/A | 563 | 375 | 1,105 | 679 |
| Other current liabilities | 18 | N/A | N/A | N/A | N/A |
| TOTAL | $2,389 | $2,356 | $2,613 | $4,383 | $3,465 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 116 | 118 | 102 | 100 | N/A |
| Other Non-Current Liabilities | 664 | 1,089 | 864 | 777 | 579 |
| TOTAL | $664 | $1,089 | $864 | $777 | $579 |
| Total Liabilities | $3,053 | $3,445 | $3,477 | $5,160 | $4,044 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,100 | 48,855 | 47,525 | 43,511 | 43,511 |
| Common Shares | 35 | 33 | 31 | 29 | 29 |
| Retained earnings | -63,511 | -62,245 | -61,073 | -59,782 | -57,769 |
| TOTAL | $-2,593 | $-3,154 | $-3,384 | $-4,983 | $-3,863 |
| Total Liabilities And Equity | $460 | $291 | $93 | $177 | $181 |